Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Presents Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Phibro Animal Health (PAHC) Misses Q4 EPS by 3c, Revenues Misss; Provides FY20 EPS Guidance Below Consensus
August 27, 2019 4:18 PM EDTPhibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.33, $0.03 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $204 million versus the consensus estimate of $206 million.
Highlights for the June 2019 quarter (compared to the June 2018 quarter)
Net sales of $204 million, a decrease of $8 million, or 4%Net income of $9 million, a decrease of $13 million, or 60%Diluted EPS of $0.22, a decrease of $0.33, or 60%Adjusted EBITDA of $26 million, a decrease of $7 million, or 20%Adjusted diluted EPS of $0.33, a decrease of $0.13, or... More